RITES and partners bag railway line project from Bangladesh Railway
A consortium led by Rail India Technical and Economic Service Limited (RITES) prevailed as the lowest bidder in a competitive bidding process held by Bangladesh ... Read More
Thermo Fisher to acquire clinical research services provider PPD for $21bn
Thermo Fisher Scientific has agreed to acquire PPD, a US-based clinical research services provider, for $47.50 per share or $20.9 billion. The consideration includes assumption ... Read More
Cleveron introduces Cleveron 701 semi-autonomous last mile delivery vehicle
Cleveron, an Estonian parcel delivery robotics company, has introduced Cleveron 701 - its new unmanned semi-autonomous last mile delivery vehicle. Cleveron 701 is said to ... Read More
Russian retailer Magnit introduces delivery service in 14 more cities
Russian retailer Magnit said that it has launched its own express delivery service in 14 more cities. According to the retailer, convenience stores in Ufa, ... Read More
Kerry Group suspends talks with Kerry Co-Operative regarding dairy business
Kerry Group has confirmed that talks with Kerry Co-Operative Creameries pertaining to a potential transaction for its dairy-related businesses in Ireland and the UK have ... Read More
Tata Motors Group sells more than 3.3 lakhs vehicles in Q4 FY21
Tata Motors Group has registered 3,30,125 nos. in its global wholesales in the fourth quarter of the fiscal year 2021 (Q4 FY21), a growth of ... Read More
Carlyle Group acquires majority stake in cosmetics firm Beautycounter
The Carlyle Group has acquired a majority stake in Beautycounter from Counter Brands in a deal that values the US cosmetics company at $1 billion. ... Read More
Russia’s RDIF gets Indian approval for Sputnik V Covid-19 vaccine
The Russian Direct Investment Fund (RDIF) has announced that the Sputnik V Covid-19 vaccine has been approved for use in India by the Drug Controller ... Read More
Dr. Reddy’s secures EUA for Sputnik V vaccine in India for Covid-19 prevention
Dr. Reddy’s Laboratories has secured permission from the Drug Controller General of India (DCGI) for importing the Sputnik V vaccine into India under emergency use ... Read More
Chronos-3 trial results : Aliqopa, rituximab combo meets primary endpoint of PFS, says Bayer
Chronos-3 trial results : Bayer said that the investigational combination of Aliqopa (copanlisib) and rituximab considerably increased progression-free survival (PFS) in patients having relapsed indolent ... Read More